# DalCor Pharmaceuticals

> DalCor Pharmaceuticals is a clinical-stage biopharmaceutical company (founded 2015, Montreal, with
> offices in Zug, Leatherhead and Sarasota) developing dalcetrapib, positioned as the first
> pharmacogenetic precision medicine in cardiovascular disease, for patients carrying the ADCY9
> rs1967309 AA genotype. DalCor runs no developer program and publishes no product API. The only
> machine-readable surface it exposes is the anonymously readable WordPress REST content API behind
> dalcorpharma.com, which serves the bilingual English/French corporate site.

<!--
generated: 2026-08-04
method: generated
source: apis.yml + the artifacts in this repo; https://dalcorpharma.com/llms.txt returns 404
note: DalCor does not publish an llms.txt. This file was generated by the API Evangelist enrichment
      pipeline from the company's public surface and is not authored or endorsed by DalCor.
-->

## Read this first

- Send a normal browser **User-Agent**. The Cloudflare edge answers an absent or default User-Agent
  with HTTP 403 — including on the JSON routes.
- Discover routes at `https://dalcorpharma.com/wp-json/wp/v2`, **not** at `/wp-json/`. The root index
  is suppressed on this deployment and returns empty `namespaces` and `routes` arrays.
- Text fields are objects with a `rendered` HTML string (`title.rendered`, `content.rendered`).
  Strip HTML before use.
- Add `wpml_language=en` or `wpml_language=fr` to select the language edition.
- This is a corporate content surface, not a supported product. There is no documentation, no
  support channel, no SLA and no changelog for it.

## APIs

- [DalCor Pharmaceuticals Content API](https://dalcorpharma.com/wp-json): Anonymously readable
  WordPress REST API exposing press releases, corporate and clinical-programme pages, the media
  library, categories and cross-content search, in English and French.
- [WordPress REST API handbook](https://developer.wordpress.org/rest-api/): the upstream reference
  that describes the wp/v2 contract DalCor's site implements.

## Specs

- [OpenAPI 3.1 (derived)](openapi/dalcor-pharmaceuticals-content-openapi.yml): 18 read operations
  derived from the published wp/v2 route index and verified live on 2026-08-04.
- [Overlay](overlays/dalcor-pharmaceuticals-content-overlay.yaml): API Evangelist annotations.
- [Authentication](authentication/dalcor-pharmaceuticals-authentication.yml)
- [Conventions](conventions/dalcor-pharmaceuticals-conventions.yml)
- [Error catalog](errors/dalcor-pharmaceuticals-problem-types.yml)
- [Data model](data-model/dalcor-pharmaceuticals-data-model.yml)
- [Conformance](conformance/dalcor-pharmaceuticals-conformance.yml)
- [Lifecycle](lifecycle/dalcor-pharmaceuticals-lifecycle.yml)
- [Domain security](security/dalcor-pharmaceuticals-domain-security.yml)
- [Well-known probe results](well-known/dalcor-pharmaceuticals-well-known.yml)

## Key operations

- `listPosts` — `GET /wp-json/wp/v2/posts` — the press-release stream (24 EN, 6 FR).
- `listPages` — `GET /wp-json/wp/v2/pages` — the corporate and scientific site (17 EN, 15 FR).
- `getPage` — `GET /wp-json/wp/v2/pages/{id}` — e.g. 60 About DalCor, 75 Management, 110 Board of
  Directors, 135 Partners, 149 Dalcetrapib History, 154 Precision Medicine, 144 Cardiovascular
  Diseases, 159 Publications, 293 dal-GenE trial, 594 Dal-GenE-2 trial, 1260 DAL-302 study
  information for clinical trial sites.
- `search` — `GET /wp-json/wp/v2/search?search=…` — cross-content search.
- `listCategories` — `GET /wp-json/wp/v2/categories` — two terms; 13 is `press-releases`.
- `listMedia` — `GET /wp-json/wp/v2/media` — 54 attachments including congress poster assets.

## Company

- [Website](https://dalcorpharma.com/)
- [About DalCor](https://dalcorpharma.com/about/)
- [Management](https://dalcorpharma.com/about/management/)
- [Board of Directors](https://dalcorpharma.com/about/board-of-directors/)
- [Science: Cardiovascular Diseases](https://dalcorpharma.com/science/cardiovascular-diseases/)
- [Science: Dalcetrapib History](https://dalcorpharma.com/science/dalcetrapib/)
- [Science: Precision Medicine for Cardiovascular Diseases](https://dalcorpharma.com/science/precision-medicine-for-cardiovascular-diseases/)
- [Publications](https://dalcorpharma.com/science/publications/)
- [dal-GenE trial (DAL-301)](https://dalcorpharma.com/dal-gene-trial/)
- [Dal-GenE-2 trial (DAL-302)](https://dalcorpharma.com/dal-gene-2-trial/)
- [DAL-302 Study: Information for Clinical Trial Sites](https://dalcorpharma.com/dal-302-study/)
- [Press Releases](https://dalcorpharma.com/press-releases/) ([RSS](https://dalcorpharma.com/feed/))
- [Contact Us](https://dalcorpharma.com/contact-us/) — info@DalCorpharma.com
- [Privacy Policy](https://dalcorpharma.com/privacy-policy/)
- [LinkedIn](https://www.linkedin.com/company/dalcor-pharmaceuticals/)
- French edition: [dalcorpharma.com/fr/](https://dalcorpharma.com/fr/)

## Not published

Recorded so an agent stops looking. Probed 2026-08-04, all 404 or non-resolving:
`/llms.txt`, `/openapi.json`, `/swagger.json`, `/api-docs`, `/.well-known/security.txt`,
`/.well-known/api-catalog`, `/.well-known/agent-card.json`, `/.well-known/agent.json`,
`/.well-known/openid-configuration`, `/.well-known/oauth-authorization-server`, `/terms`.
No MCP server, no SDKs or packages in any registry, no first-party GitHub organization, no status
page, no trust center, no vulnerability-disclosure policy, no terms of use.